Trademark: 88788969
Status Date
Tuesday, December 13, 2022
Registration Number
6925355
Registration Date
Tuesday, December 13, 2022
Filing Date
Friday, February 7, 2020
Published for Opposition
Tuesday, September 22, 2020
5 Pharmaceutical preparations, namely, compounds for use in treating addiction, substance abuse and dependence, diseases and disorders of the central nervous system, cancer, reward disorders, psychiatric and neurodegenerative diseases and disorders in the nature of schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, and bipolar disorder; pharmaceutical preparations for use in treating cardiovascular diseases and metabolic diseases; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidaemia; Pharmaceutical preparations, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; pharmaceutical preparations in the nature of compounds, namely, small molecules and chemical compounds for use in opioid modulation for treating opioid use disorders
36 Providing grants to organizations dedicated to patient focused medical research; funding service awards, namely, providing grants to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders; Providing insurance information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing insurance information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services, namely, insurance eligibility review and verification being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment in the health industry; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs
35 Administration and management of an annual competitive award program in the nature of research grants for scientific research; Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about processing online prescription orders in retail pharmacies regarding pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients
45 Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and/or administer prescribed medication
44 Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about pharmaceutical products relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Dec 13, 2022
Notice Of Registration Confirmation Emailed
Dec 13, 2022
Registered-Principal Register
Nov 9, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 8, 2022
Allowed Principal Register - Sou Accepted
Nov 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Statement Of Use Processing Complete
Oct 28, 2022
Use Amendment Filed
Nov 7, 2022
Sou Extension 4 Granted
Oct 28, 2022
Sou Extension 4 Filed
Nov 7, 2022
Case Assigned To Intent To Use Paralegal
Oct 28, 2022
Teas Extension Received
Oct 28, 2022
Teas Statement Of Use Received
May 7, 2022
Notice Of Approval Of Extension Request E-Mailed
May 5, 2022
Sou Extension 3 Granted
May 5, 2022
Sou Extension 3 Filed
May 5, 2022
Teas Extension Received
Nov 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2021
Sou Extension 2 Granted
Nov 16, 2021
Sou Extension 2 Filed
Nov 16, 2021
Teas Extension Received
May 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2021
Sou Extension 1 Granted
Apr 29, 2021
Sou Extension 1 Filed
Apr 29, 2021
Teas Extension Received
Nov 17, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 22, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 22, 2020
Published For Opposition
Sep 2, 2020
Notification Of Notice Of Publication E-Mailed
Aug 17, 2020
Approved For Pub - Principal Register
Aug 7, 2020
Teas/Email Correspondence Entered
Aug 6, 2020
Correspondence Received In Law Office
Aug 6, 2020
Teas Response To Office Action Received
Apr 28, 2020
Notification Of Non-Final Action E-Mailed
Apr 28, 2020
Non-Final Action E-Mailed
Apr 28, 2020
Non-Final Action Written
Apr 28, 2020
Assigned To Examiner
Feb 11, 2020
New Application Office Supplied Data Entered In Tram
Feb 11, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
